2Puppo F, Toree F, Contini P, et al. Soluble beta2-mu-associated and beta2-mu-free HLA class I heavy chain serum levels in interferon-alpha nonresponder chronic hepatitis C patients. Markers of immune activation, and response to antiviral retreatment. J Clin Immunol, 2000,20:486-490.
2Adamashvili I,Fraser P A,McDonald J C.Association of serum concentration of soluble class I HLAwith HLA allotypes[].Transplantation.1996
3Mansueto S,Vitale G,Mocciaro C,et al.Modifications of general parameters of immune activation in the sera of Sicilian patients with boutonneuse fever[].Clinical and Experimental Immunology.1998
4Koelman C,Mulder A,Jutte N,et al.The application of human monoclonal antibodies for monitoring donor derived soluble HLA class I molecules in the serum of heart transplant recipients[].Human Immunology.1998
7[1]Van-RossumTG,VultOAG,HopWC,etal. Gly-cyrrhiZin-induced reduction of ALT in european patients with chronic hepatitis C.Am J Gastroenterol,2001,96(8):2432.
8[3]Van-RossumTG,De-JongFH,HopWC,et al. Pseu-doaldosteronism′ induced by intravenous glycyrrhizin treatment of chronic hepatitis C patients[J]. J Gastroen-terol Hepatol,2001,16(7):789
9[5]Yi H, Nakashima I,Isobe. Enhancement of oxide production from activated macrophages by glycyrrhizin[J]. Am J chin Med, 1996,24(3-4):271.
10[8]Nakajima N,Utsanomiya T, Kobayash M,et al. In vitro induction of anti-type-cells by glycyrrhizin[J].Burns,1996;22(8):612.
